Nice find and I agree, best to buy at these low levels as 2012 will be a good year for GenOn IMO
GenOn's current hedge profile locks in what we estimate will be trough EBITDA in 2011 and 2012. In addition, we estimate management's projected $155 million of annual synergies from its merger could be worth $2 per share and model full synergies by 2012.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.